AHMED HAQUE: Open Payments
NPI 1487184628 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 30 payments from 13 companies in 2025. Trend: 2023 $421 · 2024 $251 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $139 |
| Forte Bio-Pharma LLC | 4 | $92 |
| Saluda Medical Americas, Inc. | 3 | $62 |
| Globus Medical, Inc. | 2 | $60 |
| Boston Scientific Corporation | 2 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $51 |
| BIOTRONIK NRO, Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
Products named: KYPHON EXPRESS II KYPHOPAK TRAY, PROLATE, Evoke, Senza, JOURNAVX, XTAMPZA, RELISTOR, HORIZANT.
Industry payments across TX — which companies pay providers there.
